84
Views
0
CrossRef citations to date
0
Altmetric
Research

Alvopem® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance

, , , , & ORCID Icon
Article: 16 | Received 18 Jun 2022, Accepted 14 Jan 2023, Published online: 11 Mar 2024

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.